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 ABSTRACT 
Forensic RNA analysis is gathering pace with reports of messenger RNA analysis being used 
in case work, and with microRNA being increasingly researched. Such techniques address a 
fundamental issue in body fluid identification, namely increased specificity over existing 
chemical tests, and the incorporation of additional body fluids such as vaginal material. The 
use of RNA analysis will be of particular value to sex offences, where there can be a mixture 
of multiple body fluids from different people. The aim of this study was to determine whether 
microRNA based body fluid identification tests can be applied to mixed body fluid samples.  
Blood and saliva were acquired from volunteers and underwent total RNA extraction. Mixed 
samples were prepared using a range of ratios from 1:1 to 10:1. Each mixed sample then 
underwent a blood-saliva differentiation test developed in-house, which includes stem-loop 
reverse transcription and real-time PCR analysis. Aliquots following mixture preparation 
also underwent standard STR analysis, utilising Quantiplex and Next Generation Multiplex 
kits. 
Data relating to the development of an in-house blood-saliva differentiation test is presented, 
in which it has been demonstrated that such a test has a lower limit of detection than the 
enzymatic equivalent.  
It has been shown that not only is it possible to determine the presence of more than one body 
fluid, it is also possible to determine the major body fluid contributor as well as the minor 
contributor. 
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Introduction 
Forensic RNA analysis is increasingly being used for more definitive body fluid 
identification (BFID) with a focus on messenger RNA (mRNA) [1-5] and more increasingly 
on microRNA (miRNA) [6-11]. MicroRNA is, in theory, the preferred marker to target as it 
is more stable due to its small size (~22-26 bp) and relatively high copy numbers within the 
cells [11-17]. There are some concerns relating to its species specificity, but this may be 
resolved by using a single channel simultaneous extraction technique [18] and the associated 
DNA profile, which is human specific.  
 
Such RNA based methodologies address a particular gap in body fluid identification, namely 
the use of vaginal material specific markers. This is of obvious benefit in addressing sexual 
offences; however, such offences are also heavily associated with mixed DNA profiles and 
mixed body fluids. The interpretation of mixed DNA profiles are a particularly complex area 
in case work [19-24], and it would currently be unreasonable to assume that one contributor 
of the DNA result came from one particular body fluid over the other contributor.    
 
The aim of this study was to assess and evaluate the effect of mixed body fluids on a miRNA 
BFID test developed in-house. In addition to this, strategies for interpreting mixtures of body 
fluids were also explored. Although the issue being investigated predominantly relates to 
sexual offences, blood and saliva was used in order to obtain a relatively high number of 
samples, due to the difficulties in obtaining intimate samples.  
 
Methods and materials 
Marker selection 
Following a review of the literature in which the body fluid specificity, or miRNA markers 
were explored, a series of markers were identified. For each marker, the mature miRNA 
sequence was identified using an online microRNA database (www.mirbase.org) [25-28], 
along with their corresponding stem-loop sequences to ensure that the mature sequences were 
sufficiently different, particularly with respect to the 6bp sequence on the 3’ end. These 
markers were screened using expression data (from an in-house study) [18], and the markers 
which were deemed to be preferentially expressed in the relevant body fluid were selected for 
this study. RNU-44, a small nuclear RNA (snRNA), was used as the endogenous control [10]. 
The term ‘preferentially expressed’ is used where there was significantly more of one marker 




As stated, there appears to be issues relating to species specificity in that the markers targeted 
may also be expressed in body fluids from other species. Although it would be better if these 
were human specific, it is still an improvement over the current enzymatic tests, which are 
not only non-specific in terms of species, but can also react in the presence of non-biological 




Blood and saliva samples were acquired from a number of volunteers with informed consent 
and with ethical approval from the Applied Sciences Ethics Panel. Saliva samples were 
recovered using buccal swabs. Blood samples were acquired by using the finger prick 
method, in which Unistix lancets were used to draw blood and the blood was then spotted 
onto sterile filter paper. 
 
Sample extraction 
Total RNA were extracted from the blood and saliva samples using the buccal swab method 
of the RNeasy extraction kit (Qiagen, UK). For the blood samples, a 1cm2 section was cut out 
and treated as if it was a swab. Identical extraction methods were used for verisimilitude, as 
in case work samples the identity of the body fluid would not necessarily be known.  
  
Mixture preparation 
Samples were mixed post-extraction so that a more accurate idea of mixing ratios prior to 
analysis could be obtained. A range of mixing ratios was prepared, including 1:1, 2:1, 5:1 and 
10:1. These ratios were derived from sample volume post-extraction. Single source controls 
were also included in this study. 
 
cDNA synthesis 
Stem loop reverse transcription [32] was used to synthesise cDNA from the mature 
microRNA sequences. Commercially available MicroRNA Reverse transcription kits (Life 
Technologies, UK) were used on the Veriti Thermocycler (Life Technologies, UK) as per 
manufacturer’s instructions. The stem-loop reverse transcription primers were also available 
from Life Technologies. The mature miRNA sequences provided with the kits were checked 
against the miRBase database [25-28]. 
 
Real-time PCR 
Quantification by real-time PCR was carried out on the ABI 7500 Fast Real-Time PCR 
Machine (Life Technologies, UK). Taqman labelled probes were used as per manufacturer’s 
recommendations, with a minor modification in that the number of PCR cycles was increased 
from 40 to 50 (CtMAX), thus allowing all reactions to achieve the plateau phase. The threshold 
was automatically defined by the SDS Software and used for determining the cycle threshold 
(Ct) values.  
 
Data analysis 
∆Ct values were derived either using CtRNU44 – Ctmarker or CtMAX – Ctmarker. The ∆Ct values 
were used for subsequent data analysis. The CtMAX value was applied to single source 
samples and CtRNA44 value was applied to mixtures. For data analysis of mixtures, a 
normalising formula was derived from the 1:1 mixing ratio sample (m) to compensate for 
variance between markers and samples. This formula (below) was then applied to all 
samples, where 205 refers to marker hsa-miR-205, and 451 refers to marker hsa-miR-451.  
 
∆Ct205 – (∆Ct205m – ∆Ct451m) 
 
Results 
Single Source Results 
FIGURE 1 
The first set of results in Figure 1 relates to single source samples, which indicates a high 
expression of hsa-miR-451 in blood and a low expression of hsa-miR-205. Conversely, this 
set of results also shows a high expression of hsa-miR-205 in saliva and a low expression of 
hsa-miR-451. There is a significant difference in expression (p=0.00), and consequently, 
along with an n-value of 50, these results indicate that these two markers are more than 
sufficient to distinguish between blood and saliva. For the purpose of this study, a significant 
difference of <0.05 is deemed the threshold at which a sample can be called blood or saliva.  
 
FIGURE 2 
A blind study was carried out in which a series of blood and saliva samples were prepared 
and anonymously labelled. These samples were prepared after extraction, so that they could 
not be visually distinguished. Four such samples are shown in Figure 2. All samples were 
correctly identified as being blood or saliva (all with a p-value of 0.00). 
 
FIGURE 3 
Following the development of the in-house test, a sensitivity study was conducted in which 
10µl of blood were serially diluted. The blood was regularly tested using the leucomalachite 
green (LMG) and the Kastle-Meyer (KM) test at each stage of dilution. At a dilution of 
1:50,000, both the KM and LMG tests were negative. The miRNA BFID test was then carried 
out on the blood samples. As indicated in Figure 3, although the expression of hsa-miR-451 
and hsa-miR-205 was somewhat less, there is still a significant difference (p=0.00) between 
the two.  
 
Body fluid mixture results 
FIGURE 4 
It can be seen in Figure 4 that, whichever body fluid is the major contributor, the respective 
marker is significantly more expressed than the opposing marker. The single source body 
fluids show a relative large difference in marker expression. When the minor contributor is 
compared with the single source body fluid it can be seen that there is higher expression in 
the mixture, suggesting that the minor body fluid is actually present. Although the mixing 
ratios are not maintained post-PCR, the correct major contributor can be identified every 
time, and likewise for the minor contributor. Negative controls were included in all studies. 
  
Discussion 
The aim of this study was to apply microRNA analysis to stains containing a mixture of body 
fluids. This was achieved by carrying out stem-loop reverse transcription and real-time PCR 
on samples containing both blood and saliva, utilising body fluid specific miRNA markers.  
A test was developed in-house in which hsa-miR-451 and hsa-miR-205 were capable of 
differentiating between blood and saliva with a 100% success rate. This test underwent a 
blind study in which the body fluid was correctly identified every time. Serial dilutions of 
blood and saliva samples were carried out and the test was carried out on samples diluted 
1:50,000 (beyond the limit of detection of the enzymatic tests) with a 100% success rate.  
 
Consequently, an effective miRNA based body fluid identification test has been developed 
in-house, which is more sensitive than enzymatic based blood tests. Although it is not 
obvious why such a test is needed to differentiate between blood and saliva, this demonstrates 
the principle with a high sample number.  
 
There are also circumstances where it is not possible to definitively identify a stain as being 
blood, such as when an area that is LMG/KM +ve is not actually visible (for example a small 
drop on a black shirt or a diluted stain on a surface). In such cases, a blood vs. saliva test 
would be useful if it was necessary to determine the presence of blood, as opposed to a false 
positive or an underlying body fluid such as saliva. The sensitivity test has demonstrated that 
if an LMG/KM reaction has been observed, it is possible to get a more definitive answer 
using this test. Furthermore if an area is suspected to be blood, but no LMG/KM is detected 
(for example on a black shirt that has been laundered), then it may still be possible to detect 
the presence of blood using this miRNA BFID test.  
 
This test was then applied to the issue of mixtures. This was initially carried out in order to 
determine what the effect of mixed body fluids had on the results, mainly to determine 
whether or not it could be distinguished as a mixture. Prior to this point, the ∆Ct value was 
derived from CtMAX-Ctvalue. The need for an endogenous control was very quickly realised 
and this was implemented using RNU-44 (following an in-house screen). As RNU-44 is a 
small nuclear RNA (snRNA) rather than a true miRNA endogenous control, the 1:1 mixture 
sample was used as a control, and a formula was derived and applied to all samples.  
 The formula derived from the 1:1 mixture allowed for the correction of the relative amount of 
genetic material available in blood and saliva. For example, if the ∆Ct value for blood in the 
1:1 mixture was 5 and the ∆Ct value for saliva in the same sample was 10, then the value for 
saliva would be corrected to be equal to blood, in this case by subtracting 5 from the saliva 
∆Ct value, thus giving a new ∆Ct value for saliva as 5. This same value would then be 
subtracted from all saliva samples within that run.  
 
Following this step, the 2:1 mixture sample was not sufficient to significantly discern a major 
contributor, which is comparable with DNA mixtures in which a 2:1 mixture would be 
classed as a complex mixture rather than a simple mixture (or major/minor). At a 5:1 mixing 
ratio, the difference between the major body fluid and minor body fluid is sufficient to 
classify as a simple mixture, again, comparable to that of DNA mixtures. This was even more 
pronounced in the 10:1 mixing sample, as would be expected. 
 
Consequently, this demonstrates that the miRNA based BFID test can be used on mixed body 
fluid samples with reliable results. Not only can the mixture be identified, it is possible to 
determine the major/minor contributors. Currently, the association of a major DNA profile 
with a particular body fluid should not be carried out, given the uncertainties of the relative 
amounts of body fluids in the stain. This miRNA BFID test clearly demonstrates that this 
capability can be embedded within the forensic laboratory.  
 
At this stage, the reporting language should be fairly limited. For example, in a sample where 
the blood is the major body fluid and the saliva is the minor contributor, it should be reported 
as ‘In my opinion, the major DNA profile was more likely to be obtained from the blood 
rather than the saliva’.  
 
If a single stream strategy, such as that suggested by van der Meer et al. [18], is applied to 
this test and incorporates a full miRNA marker panel, then the language could be 
strengthened to ‘In my opinion, the major DNA profile was obtained from the blood.’ 
However, such a marker panel would need to include skin cell specific markers, and said 
markers need to be sufficient to differentiate between salivary and vaginal epithelia.  
 
Summary 
A effective in-house miRNA based body fluid identification test was developed that is 
capable of distinguishing between blood and saliva. This test, which was demonstrated to be 
more sensitive than the LMG/KM tests, was also successfully applied to mixed body fluids. 
 
Future work will involve exploring this phenomenon on the more relevant body fluids, such 
as vaginal material, seminal fluid and in particular, skin cells. Such work includes exploring 
potential case work issues and development of interpretational guidelines in partner with a 
forensic science provider and end user organisations such as the police. Finally, a future study 
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Marker name Body Fluid Mature Sequence (5’-3’) 
Hsa-mir-451[7, 30] Blood aaaccguuaccauuacugaguu 
Hsa-mir-205[7] Saliva uccuucauuccaccggagucug 
Table 1 – Selected markers along with their body fluid specificity and mature miRNA sequence. The 
underlined section indicates the 6bp tab required for stem-loop reverse transcription [25-29]. 
 
TABLE 2 
Marker name Body Fluid Expressed in... 
Hsa-mir-451 Blood Human, mouse, rat, dog, pig, Rhesus 
monkey, Zebra fish, Carolina anole, 
chimpanzee, Bornean orangutan, 
Western clawed frog 
Hsa-mir-205 Saliva Human 
RNU-44 Endogenous control Human 
 
 
Table 2 - The species in which the selected markers are expressed. These are the species known to 























Figure 1 - Bar chart indicating the expression of hsa-miR-451 and hsa-miR-205 in blood and saliva. 
The error bars represents 1 standard deviation. Paired sample T tests show a p-value of 0.00 showing 
significance difference in expression within each sample. The standard deviation for Blood/205 is 
virtually zero, thus error bars cannot be observed for this data set. Red bars indicate analysis of 





Figure 2 – A bar chart showing the results of four samples following a blind study. A, B, C and D 
refers to the sample codes. 205 refers to hsa-miR-205 and 451 refers to hsa-miR-451. All error bars 
represent one standard deviation. Red bars indicate analysis of blood samples and blue bars indicate 























Figure 3 - A bar chart indicating the expression of hsa-miR451 and hsa-miR-205 in undiluted blood 
samples and in blood samples diluted by a factor of 1:50,000. All error bars represent one standard 







Figure 4 - A bar chart indicating the expression of hsa-miR-451 and msa-miR-205 in body fluid 
stains containing a mixture of blood and saliva over a range of different mixing ratios. Single source 
blood and saliva samples are also included as controls. Red bars indicate analysis of blood markers 
(451) and blue bars indicate analysis of saliva markers (205). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
